Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MREO
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
MREO
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

MREO Similar Chart Price Prediction

The price of MREO is predicted to go up -1.67%, based on the high correlation periods with FCEL. The similarity of these two price pattern on the periods is 95.73%.

stocks logo

MREO

stocks logo

FCEL

Down: -1.67%Similarity: 95.73%

MREO Revenue Forecast

MREO EPS Forecast

MREO FAQs

What is bull’s view on MREO?

MREO stock has a bullish outlook with a price target of $10, representing a significant upside from its current price of $3.01. This optimism is driven by the company's lead product, setrusumab, in Phase 3 trials for osteogenesis imperfecta, and its strategic partnership with Ultragenyx, enhancing commercialization potential in the US and Europe. Analysts highlight strong fundamentals and market potential in rare disease therapies as key growth drivers.

What is bear's view on MREO?

MREO stock closed at $3.01 on January 31, 2025, and has shown a recent pre-market decline of 3.30%. Bears may argue that the stock faces dilution risks due to its recent filing to sell 26.64 million shares, which could pressure the price further. Additionally, despite analyst optimism with a $10 target, the current valuation reflects skepticism about near-term catalysts.

What is MREO revenue forecast for next quarter？

The market consensus for MREO's revenue in the upcoming quarter is projected to be approximately $21.303M USD.

MREO VS S&P500

Ask Intellectia about MREO

MREO Analyst's Forecast

Cory Jubinville

LifeSci Capital

Buy

2024-12-24

Price Target

$10

Upside

+162.47%

LifeSci Capital analyst Cory Jubinville initiated coverage of Mereo BioPharma with an Outperform rating and $10 price target.
Maury Raycroft

Jefferies

Strong Buy

2024-12-06

Price Target

$7

Upside

+85.68%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

BCO

Brinks Co

$96.29
1.95%
stocks logo

FLO

Flowers Foods Inc

$18.93
-2.07%
stocks logo

NWL

Newell Brands Inc

$6.66
-1.62%
stocks logo

GBDC

Golub Capital Bdc Inc

$15.56
-0.83%
stocks logo

SIM

Grupo Simec SAB de CV

$26.4
0.30%
stocks logo

AI

C3.ai Inc

$26.44
0.42%
stocks logo

KMPR

Kemper Corp

$64.95
-1.25%
stocks logo

AX

Axos Financial Inc

$66.3
0.71%
stocks logo

ASB

Associated Banc-Corp

$24.51
1.32%
stocks logo

KGS

Kodiak Gas Services Inc

$43
2.31%